✨ 9 results found - Searched 21147 records in 4ms.
Disertasi
Peran Lingkungan Mikro Tumor terhadap Kesintasan Kanker Payudara Tiga Negatif Metastatik: Kajian terhadap Ekspresi CD4, CD8, FOXP3 CD163 dan PD-L1
2023 | BY Andhika Rachman - Jeffry Beta Tenggara - Lisnawati - Aru Wisaksono Sudoyo- The Role of Tumor Microenvironment on Survival of Metastatic Triple Negative Breast Cancer: A Study on the Expression of CD4, CD8, FOXP3,CD163, and PD-L1.
- Nomor Panggil D23035fk
Tesis
Perbandingan Nilai Rasio Neutrofil-Limfosit Pasien Kanker Payudara Metastasis Triple Negatif dan Non Triple Negatif Tahun 2017-2023 di RSCM
2024 | BY Anna Mira Lubis - Ikrar Syahmar - Wulyo Rajapto- Comparison of Neutrophil-Lymphocyte Ratio between Triple Negative and Non Triple Negative Metastatic Breast Cancer Patients at RSCM in 2017-2023.
- Nomor Panggil T24245fk
Skripsi
Impacts of Manganese Superoxide Dismutase Gene Knockout on Oct4 and Sox2 Protein Expression in Triple Negative Breast Cancer Cells
2022 | BY Electra Amara Florence - Septelia Inawati Wanandi- Dampak Knockout Gen Manganese Superoxide Dismutase pada Ekspresi Protein Oct4 dan Sox2 pada Sel Kanker Payudara Triple Negatif.
- Nomor Panggil S22193fk
Tesis
Evaluasi knockout gen Manganese Superoxide Dismutase (MnSOD) terhadap kemampuan penghambatan laju pertumbuhan serta peningkatan apoptosis sel kanker payudara triple negative BT-549
2022 | BY Niken Rahmah Ghanny - Novi Silvia Hardiany - Septelia Inawati Wanandi- Evaluation of Manganese Superoxide Dismutase (MnSOD) gene knockout toward the growth and apoptosis of BT-549 triple negative breast cancer cells.
- Nomor Panggil T22507fk
Tesis
Penanda Sel Punca Kanker Aldehyde Dehydrogenase 1 (ALDH1) sebagai Faktor Prognostik pada Pasien Kanker Payudara Triple Negative
2018 | BY Dian Kurnia - H. Zafiral Azdi Albar - Samuel J Haryono- Aldehyde Dehydrogenase 1 (ALDH1) Cancer Stem Cells Marker As Prognostic Factor in Triple Negative Breast Cancer.
- Nomor Panggil T18170fk
Tesis
Pengembangan Konjugat Cetuximab – Puromisin sebagai Imunotoksin untuk Menghambat Viabilitas Sel Kanker Payudara Tipe Triple Negative
2021 | BY Diah Puspitasari - Septelia Inawati Wanandi - Mohamad Sadikin- Development of cetuximab-puromycin conjugate as an immunotoxin to inhibit the viability of triple negative breast cancer cells.
- Nomor Panggil T21521fk
Tesis
PD-L1 Sebagai Faktor Prognosis Kesintasan Pada Pasien Kanker Payudara Triple Negative
2021 | BY Ubaidillah - Dhanasari Vidiawati Tresna - Hartono Tjahjadi - Bayu Brahma - Ahmad Kurnia- PD-L1 As Prognostic Factor for Survival in Triple Negative Breast Cancer Patient.
- Nomor Panggil T21371fk
Tesis
Kesintasan Lima Tahun Kanker Payudara Tripel Negatif di RSCM dan Faktor Klinikopatogis yang Memengaruhinya
2020 | BY Ihza Fachriza - Erwin Danil Yulian- Five Years Survival of Triple Negative Breast Cancer in Cipto Mangunkusumo Hospital and Influencing Clinicopathological Factors.
- Nomor Panggil T20350fk
Disertasi
Peran TMEPAI (transmembrane prostate androgen-induced) yang diinduksi TGF-β pada resistensi sel kanker payudara triple negative terhadap doksorubisin
2019 | BY Bantari Wisynu Kusuma Wardhani- The role of TGF-β-induced TMEPAI (transmembrane prostate androgen-induced) in the resistance of triple negative breast cancer cell to doxorubicin.
- Nomor Panggil D19041fk